These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 5082511

  • 1. Detection and properties of an acid -galactosidase (ceramidetrihexosidase) in normal human urine.
    Rietra PJ, Tager JM, Borst P.
    Biochim Biophys Acta; 1972 Oct 25; 279(3):436-45. PubMed ID: 5082511
    [No Abstract] [Full Text] [Related]

  • 2. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.
    Brady RO, Tallman JF, Johnson WG, Gal AE, Leahy WR, Quirk JM, Dekaban AS.
    N Engl J Med; 1973 Jul 05; 289(1):9-14. PubMed ID: 4196713
    [No Abstract] [Full Text] [Related]

  • 3. Preparation and properties of an affinity column adsorbent for differentiation of multiple forms of -galactosidase activity.
    Mapes CA, Sweeley CC.
    J Biol Chem; 1973 Apr 10; 248(7):2461-70. PubMed ID: 4121458
    [No Abstract] [Full Text] [Related]

  • 4. Correction of the enzymic defect in cultured fibroblasts from patients with Fabry's disease: treatment with purified alpha-galactosidase from ficin.
    Dawson G, Matalon R, Li YT.
    Pediatr Res; 1973 Aug 10; 7(8):684-90. PubMed ID: 4732107
    [No Abstract] [Full Text] [Related]

  • 5. Fabry's disease as an -galactosidosis: evidence for an -configuration in trihexosyl ceramide.
    Bensaude I, Callahan J, Philippart M.
    Biochem Biophys Res Commun; 1971 May 21; 43(4):913-8. PubMed ID: 5563756
    [No Abstract] [Full Text] [Related]

  • 6. Studies on galactosyl ceramide and lactosyl ceramide beta-galactosidase.
    Wenger DA.
    Chem Phys Lipids; 1974 Dec 21; 13(4):327-9. PubMed ID: 4452215
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The inhibitor-sensitive sites of galactosyl ceramide galactosidase.
    Arora RC, Lin YN, Radin NS.
    Arch Biochem Biophys; 1973 May 21; 156(1):77-83. PubMed ID: 4738302
    [No Abstract] [Full Text] [Related]

  • 9. Human kidney alpha-galactosidase. Multiplicity and enzyme activities for ceramide trihexoside and some aryl alpha-galactosides.
    Kano I, Yamakawa T.
    J Biochem; 1974 Feb 21; 75(2):347-54. PubMed ID: 4837447
    [No Abstract] [Full Text] [Related]

  • 10. Hydrolysis of ceramide trihexoside by a specific -galactosidase from human liver.
    Ho MW.
    Biochem J; 1973 May 21; 133(1):1-10. PubMed ID: 4721621
    [Abstract] [Full Text] [Related]

  • 11. Investigation of the alpha-galactosidase deficiency in Fabry's disease using antibodies against the purified enzyme.
    Rietra PJ, Molenaar JL, Hamers MN, Tager JM, Borst P.
    Eur J Biochem; 1974 Jul 01; 46(1):89-98. PubMed ID: 4212108
    [No Abstract] [Full Text] [Related]

  • 12. Evidence for a terminal -D-galactopyranosyl residue in galactosylgalactosylglucosylceramide from human kidney.
    Clarke JT, Wolfe LS, Perlin AS.
    J Biol Chem; 1971 Sep 25; 246(18):5563-9. PubMed ID: 5096082
    [No Abstract] [Full Text] [Related]

  • 13. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes.
    Desnick RJ, Allen KY, Desnick SJ, Raman MK, Bernlohr RW, Krivit W.
    J Lab Clin Med; 1973 Feb 25; 81(2):157-71. PubMed ID: 4683418
    [No Abstract] [Full Text] [Related]

  • 14. An enzymological approach to the lipidoses.
    Tallman JF, Pentchev PG, Brady RO.
    Enzyme; 1974 Feb 25; 18(1):136-49. PubMed ID: 4211795
    [No Abstract] [Full Text] [Related]

  • 15. The adnormal biochemistry of inherited disorders of lipid metabolism.
    Brady RO.
    Fed Proc; 1973 Jun 25; 32(6):1660-7. PubMed ID: 4351098
    [No Abstract] [Full Text] [Related]

  • 16. Fabry's disease: evidence for a physically altered -galactosidase.
    Ho MW, Beutler S, Tennant L, O'Brien JS.
    Am J Hum Genet; 1972 May 25; 24(3):256-66. PubMed ID: 5028966
    [No Abstract] [Full Text] [Related]

  • 17. The glycosphingolipids and glycosyl hydrolases of human blood platelets.
    Snyder PD, Desnick RJ, Krivit W.
    Biochem Biophys Res Commun; 1972 Mar 10; 46(5):1857-65. PubMed ID: 5015230
    [No Abstract] [Full Text] [Related]

  • 18. Correction of enzymatic deficiencies by renal transplantation: Fabry's disease.
    Desnick RJ, Simmons RL, Allen KY, Woods JE, Anderson CF, Najarian JS, Krivit W.
    Surgery; 1972 Aug 10; 72(2):203-11. PubMed ID: 4559379
    [No Abstract] [Full Text] [Related]

  • 19. Studies on isolation and characterization of ceramide trihexosidase.
    Sweeley CC, Mapes CA.
    Birth Defects Orig Artic Ser; 1973 Mar 10; 9(2):206-13. PubMed ID: 4373101
    [No Abstract] [Full Text] [Related]

  • 20. Presence of alpha-anomeric glycosidic configuration in the glycolipids accumulated in kidney with Fabry's disease.
    Handa S, Ariga T, Miyatake T, Yamakawa T.
    J Biochem; 1971 Mar 10; 69(3):625-7. PubMed ID: 5551655
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.